Drax Group PLC
10 January 2007
Drax Group plc
(Symbol: DRX)
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
Drax Group plc
2. Name of shareholder having a major interest
AMVESCAP PLC
3. Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18
Shareholder named in 2 above and its subsidiary companies on behalf of
discretionary clients.
AMVESCAP has advised that none of the shares contained in this notification are
beneficially owned by AMVESCAP.
See also the comments below under box 14 - Any Additional Information.
4. Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them
ABN Amro Bank 151,947
Bank of Ireland (Dublin) 856,070
Bank Austria (Frankfurt) 58,274
Banque Paribas (Frankfurt) 110,537
Banque Paribas Jersey SA 50,369
Credit Agricole Indosuez (Luxembourg) 69,584
Chase Nominees 985,210
Vidacos 47,179,001
Deutsche Apothecar Und Aerzte 9,503
Dresdner Bank (Frankfurt) 16,104
Erst Bank (Vienna) 5,703
WestLB Dusseldorf 6,944
HSBC Bank plc (London) 1,029,176
Kommunal Kreit Deportbank AG (Austria) 12,796
Mellon Bank, Pittsburgh 531,569
Morgan Stanley (London) 17,200
B.Metzler sel.Sohn & Co.KG (Frankfurt) 100,714
SCHI (Santander Central Hispanio Investment) 22,718
State Street Trust & Banking Co (London) 7,073,017
Northern Trust Company (London) 921,320
WGZ Bank 19,724
5. Number of shares / amount of stock acquired
Not Advised
6. Percentage of issued class
Not Advised
7. Number of shares / amount of stock disposed
N/A
8. Percentage of issued class
N/A
9. Class of security
Ordinary Shares of 11 1/29 pence each
10. Date of transaction
On 9 January 2007
11. Date company informed
9 January 2007
12. Total holding following this notification
59,227,480
13. Total percentage holding of issued class following this notification
16.05%
14. Any additional information
Figures are based on shares in issue of 368,921,151
Based on:
(a) information received previously from Amvescap acting as agent for INVESCO
Perpetual; and
(b) further enquiries made,
Drax understands that at least 40,599,698 shares (as listed under Vidacos
Nominees in box 4 above) were also the subject of the separate notification made
on 19 October 2006 (RNS Number 7444K) in respect of INVESCO Perpetual UK
Investment Series, which makes up that organisation's 11.00% interest.
15. Name of contact and telephone number for queries
Phil White (01757 612167)
16. Name and signature of authorised company official responsible for making
this notification
Peter Rothwell, Company Secretary
Date of notification
10 January 2007
ENDS
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.